Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
04/2003
04/17/2003US20030073845 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
04/17/2003US20030073819 PGC-1, a novel brown fat PPARgamma coactivator
04/17/2003US20030073746 Method for treating drug-induced constipation
04/17/2003US20030073732 Antiinflammatory agents
04/17/2003US20030073727 Central nervous system disorders
04/17/2003US20030073723 Antiinflammatory agents; rheumatic diseases; antiallergens
04/17/2003US20030073720 Tryptase inhibitors
04/17/2003US20030073719 Chiral salt resolution
04/17/2003US20030073718 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease
04/17/2003US20030073715 Nasal administering; side effect reduction
04/17/2003US20030073712 Antiinflamamtory agents; antiischemic agents
04/17/2003US20030073704 Analgesics; antidiabetic agents; antiinflamamtory agents
04/17/2003US20030073700 Central nervous system disorders; Parkinson's disease, Huntington's disease; psycological disorders
04/17/2003US20030073699 Compounds and methods to treat cardiac failure and other disorders
04/17/2003US20030073698 Nitrogen-based camptothecin derivatives
04/17/2003US20030073693 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
04/17/2003US20030073685 Nitric oxide synthase inhibitor; antiinflammatory agents
04/17/2003US20030073684 Respiratory system disorders; cardiovascular disorders; hemorrhage therapy
04/17/2003US20030073682 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
04/17/2003US20030073677 Synergistic mixtures; anticancer agents; 2-(2 -methyl-4-thiazolyl)ethenyl)-4,17-dioxabicyclo(14.1.0)heptadecane-5,9 -dione or 4-aza-17-oxabicyclo(14.1.0) heptadecane-5,9-dione or 1-aza-13-cyclohexadecene-2,6-dione or 1-oxa-13-cyclohexadecene-2,6-dione derivatives
04/17/2003US20030073669 N-heterocyclic derivatives as NOS inhibitors
04/17/2003US20030073656 Using a tyrosine kinase receptor inhibitor
04/17/2003US20030073628 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
04/17/2003US20030073167 DNA encoding SNORF36 receptors
04/17/2003US20030073080 Genetically engineered viral nucleotide sequences for use as tool in gene therapy and vaccine development
04/17/2003US20030072841 Polybutene containing chewing gum and confection
04/17/2003US20030072824 Having anti-oxidant, gastric mucosa injury inhibiting, aldose reductase inhibiting, blood glucose level elevation inhibiting action, platelet agglutination accelerating action, alcohol absorption inhibition, anti-inflammation properties
04/17/2003US20030072804 Use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by the body
04/17/2003US20030072766 Comprising antiserum raised against a flagellaless Campylobacter strain for prophylaxis of Campylobacter colonisation in animals
04/17/2003US20030072736 Human tumor necrosis factor receptor TR16
04/17/2003CA2473970A1 Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
04/17/2003CA2464662A1 Modulation of the expression of genes dependent on stat-1
04/17/2003CA2463364A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
04/17/2003CA2463339A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound
04/17/2003CA2463198A1 Pyrrolidinone derivatives
04/17/2003CA2462892A1 Human 3 relaxin
04/17/2003CA2462881A1 Intraorally disintegrating valdecoxib compositions prepared by spray drying process
04/17/2003CA2462876A1 Compositions for and methods of treating and preventing sirs/sepsis
04/17/2003CA2462862A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists
04/17/2003CA2462301A1 Para-amino benzoic acids as integrin antagonists
04/17/2003CA2461064A1 Inhibition of stat-1
04/17/2003CA2460476A1 Protein modification and maintenance molecules
04/17/2003CA2460341A1 Methods of treating liver fibrosis and hepatitis c virus infection
04/17/2003CA2458645A1 Intracellular signaling molecules
04/17/2003CA2458456A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
04/16/2003EP1302542A1 Novel physiologically active peptide and use thereof
04/16/2003EP1302476A1 Reduced fk228 and use thereof
04/16/2003EP1302201A1 Pharmaceutical composition improved in peroral absorbability
04/16/2003EP1301797A2 Antimicrobial agent
04/16/2003EP1301598A2 Cell cycle proteins and mitosis-associated molecules
04/16/2003EP1301595A2 G-protein coupled receptors
04/16/2003EP1301592A2 Recombinant bacterial phytases and uses thereof
04/16/2003EP1301539A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
04/16/2003EP1301535A2 G-protein coupled receptors
04/16/2003EP1301528A2 Peptides as ns3-serine protease inhibitors of hepatitis c virus
04/16/2003EP1301524A1 B7-like polynucleotides, polypeptides, and antibodies
04/16/2003EP1301522A1 Novel compounds and methods
04/16/2003EP1301514A1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use
04/16/2003EP1301507A2 Mannich base prodrugs of 3 - (pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
04/16/2003EP1301500A1 Nitrosated and nitrosylated taxanes, compositions and methods of use
04/16/2003EP1301495A2 Inhibitors of copper-containing amine oxidases
04/16/2003EP1301490A2 5-substituted 2-aryl-4-pyrimidinones
04/16/2003EP1301482A1 Cyclic amine phenyl beta-3 adrenergic receptor agonists
04/16/2003EP1301464A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments
04/16/2003EP1301212A1 Pharmaceutically active compound
04/16/2003EP1301207A2 Compositions for treating bacterial infections, containing an oxazolidinone compound, sulbactam and and ampicillin
04/16/2003EP1301200A2 Peptide pharmaceutical formulations
04/16/2003EP1301190A2 Pepsin inhibition by alginates
04/16/2003EP1240159A4 Improved omeprazole process and compositions thereof
04/16/2003EP1185254B1 Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same
04/16/2003EP1181047B1 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
04/16/2003EP1181017B1 Metalloprotease inhibitors
04/16/2003EP1150981B1 Use of (1r, 4s)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol in hbv
04/16/2003EP1112003B1 Use of a viscosity modulating polymer material for reducing tooth erosion
04/16/2003EP1104288A4 Orally disintegrable tablet forming a viscous slurry
04/16/2003EP1056449B1 20-hete antagonists and agonists
04/16/2003EP1024807B1 Use of the compound 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate for the production of an anti-inflammatory drug with prevention of gastric hypersecretion and renal impairment
04/16/2003EP0977565B1 Pharmaceutical composition comprising a tricyclic compound with enhanced stability, absorbability and low irritation potential
04/16/2003EP0893998B1 Colonic delivery of nicotine to treat inflammatory bowel disease
04/16/2003EP0824544B1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
04/16/2003EP0801554B1 Formulations and methods for reducing skin irritation
04/16/2003EP0649414B1 Opioid diarylmethylpiperazines and piperidines
04/16/2003CN1411504A Liver tissue source
04/16/2003CN1411460A Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
04/16/2003CN1411458A Saccharin derivatives as orally active elastase inhibitors
04/16/2003CN1411447A Polymorphic crystalline forms of celecoxib
04/16/2003CN1411446A Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors
04/16/2003CN1411440A Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
04/16/2003CN1411435A Novel use of phenyl hetero alkylamine derivatives
04/16/2003CN1411378A Method for production of egg containing anti-pathogenic bacteria specific antibodies (IgY) and yogurt and ice cream containing IgY
04/16/2003CN1411376A Novel helicobacter pylori-binding substances and use thereof
04/16/2003CN1411374A Substituted piperazine and piperidine calcium channel blockers
04/16/2003CN1411347A Composition for improving proliferative response during adapation of gastrointestinal tract and use in short bowel syndrome
04/16/2003CN1410419A Method and composition for treating or preventing bacterial infection
04/16/2003CN1410120A Medicine for treating gastropathy
04/16/2003CN1410119A Rhubarb ground beetle pill
04/16/2003CN1410108A Medicine for treating diarrhea and its preparation method
04/16/2003CN1410099A Renshujianwei granules stomachia and its preparation method
04/16/2003CN1410092A Oral liquid for treating gastritis
04/16/2003CN1410083A Yakong preparation (dental medicine) and its production method
1 ... 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 ... 1258